Advantages and Outcomes of Epithelium-On Crosslinking episode artwork

EPISODE · Nov 20, 2025 · 34 MIN

Advantages and Outcomes of Epithelium-On Crosslinking

from Ophthalmology off the Grid by Eyetube · host Eyetube

In this episode, hosts Blake Williamson, MD, MPH, and Gary Wörtz, MD, invite Kenneth Beckman, MD, to discuss the recent FDA approval of Epioxa (Glaukos), an advancement in corneal crosslinking for the treatment of keratoconus that does not require the removal of the corneal epithelium. Dr. Beckman shares insights into the benefits and outcomes of this procedure and details from clinical trials.

In this episode, hosts Blake Williamson, MD, MPH, and Gary Wörtz, MD, invite Kenneth Beckman, MD, to discuss the recent FDA approval of Epioxa (Glaukos), an advancement in corneal crosslinking for the treatment of keratoconus that does not require the removal of the corneal epithelium. Dr. Beckman shares insights into the benefits and outcomes of this procedure and details from clinical trials.

NOW PLAYING

Advantages and Outcomes of Epithelium-On Crosslinking

0:00 34:11

No transcript for this episode yet

We transcribe on demand. Request one and we'll notify you when it's ready — usually under 10 minutes.

Frequently Asked Questions

How long is this episode of Ophthalmology off the Grid by Eyetube?

This episode is 34 minutes long.

When was this Ophthalmology off the Grid by Eyetube episode published?

This episode was published on November 20, 2025.

What is this episode about?

In this episode, hosts Blake Williamson, MD, MPH, and Gary Wörtz, MD, invite Kenneth Beckman, MD, to discuss the recent FDA approval of Epioxa (Glaukos), an advancement in corneal crosslinking for the treatment of keratoconus that does not require...

Can I download this Ophthalmology off the Grid by Eyetube episode?

Yes, you can download this episode by clicking the download button on the episode player, or subscribe to the podcast in your preferred podcast app for automatic downloads.
URL copied to clipboard!